OncoTargets and Therapy
Volume 14, 2021 - Issue
Open access
105
Views
5
CrossRef citations to date
0
Altmetric
Original Research
Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice
Mª del Carmen Álamo1 Oncology Department, Hospital Universitario Virgen Macarena, Sevilla, SpainView further author information
, Sebastian Ochenduszko2 Oncology Department, Hospital Universitario Dr. Peset, Valencia, SpainView further author information
, Guillermo Crespo3 Oncology Department, Hospital Universitario de Burgos, Burgos, SpainView further author information
, Mónica Corral4 Oncology Department, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spainhttps://orcid.org/0000-0002-6443-8701View further author information
, Juana Oramas5 Oncology Department, Hospital Universitario de Canarias, Santa Cruz de Tenerife, SpainView further author information
, Pilar Sancho6 Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, SpainView further author information
, Javier Medina7 Oncology Department, Hospital Universitario Virgen de la Salud, Toledo, SpainView further author information
, Fernando Garicano8 Oncology Department, Hospital de Galdakao, Bizkaia, SpainView further author information
, Pedro López9 Oncology Department, Complejo Hospitalario General de Jaén, Jaén, SpainView further author information
, Begoña Campos Balea10 Oncology Department, Hospital Lucus Augusti, Lugo, Spainhttps://orcid.org/0000-0002-8927-9129View further author information
, Analia Rodríguez Garzotto11 Medical Department and Strategy, Roche S.A, Madrid, SpainView further author information
& Eva Muñoz-Couselo12 Oncology Department, Hospital Universitario Vall d´Hebron, Barcelona, Spain;13 VHIO Vall d’Hebron Institute on Oncology, Barcelona, SpainCorrespondence[email protected]
View further author information
show allView further author information
Pages 5345-5352
|
Published online: 27 Nov 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.